MedPath

RSPR Pharma AB

RSPR Pharma AB logo
🇸🇪Sweden
Ownership
Private
Established
2006-01-01
Employees
1
Market Cap
-
Website
http://www.pulmologix.com

Safety and Efficacy of CRD007 in Adult Asthma Subjects

Phase 2
Completed
Conditions
Asthma
Interventions
Drug: Placebo
First Posted Date
2015-11-25
Last Posted Date
2017-02-27
Lead Sponsor
RSPR Pharma AB
Target Recruit Count
168
Registration Number
NCT02615080
Locations
🇧🇬

MHAT St. Ivan Rilski-2003 Ltd., Department of Internal Medicine, Dupnitsa, Bulgaria

🇧🇬

SHATPPD - Pazardzhik EOOD, Department of phthisiatrics pneumonia and pulmonary functional diagnostics, Pazardzhik, Bulgaria

🇧🇬

Medical Center - Razgrad OOD, Office of Pneumonology and Phthisiatry, Razgrad, Bulgaria

and more 19 locations

RSPR-007 Mannitol Challenge Trial

Phase 2
Completed
Conditions
Asthma
Interventions
Other: Placebo
First Posted Date
2015-11-20
Last Posted Date
2016-11-16
Lead Sponsor
RSPR Pharma AB
Target Recruit Count
24
Registration Number
NCT02609334
Locations
🇩🇰

Hvidovre Hospital, Hvidovre, Denmark

🇩🇰

Bisbebjerg Hospital, København NV, Denmark

Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
First Posted Date
2015-08-07
Last Posted Date
2015-08-07
Lead Sponsor
RSPR Pharma AB
Target Recruit Count
24
Registration Number
NCT02517372

Pharmacokinetics of CRD007 in Patients With Abdominal Aorta Aneurisms.

Phase 1
Completed
Conditions
Abdominal Aortic Aneurisms
Interventions
First Posted Date
2012-11-08
Last Posted Date
2012-11-29
Lead Sponsor
RSPR Pharma AB
Target Recruit Count
18
Registration Number
NCT01723618
Locations
🇩🇰

Department of Vascular Surgery Viborg Hospital, Viborg, Denmark

CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers

Phase 2
Completed
Conditions
Becker Muscular Dystrophy
Duchenne Muscular Dystrophy
Interventions
First Posted Date
2012-02-29
Last Posted Date
2012-10-02
Lead Sponsor
RSPR Pharma AB
Registration Number
NCT01540604

CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)

Phase 2
Completed
Conditions
Abdominal Aortic Aneurysm
Interventions
Drug: CRD007 matching placebo
First Posted Date
2011-05-16
Last Posted Date
2012-11-06
Lead Sponsor
RSPR Pharma AB
Registration Number
NCT01354184
Locations
🇸🇪

Uppsala University Hospital, Uppsala, Sweden

🇸🇪

Borås Hospital, Department of Surgery, Borås, Sweden

🇸🇪

Mälarsjukhuset, Team Kärl Kir. Klin., Eskilstuna, Sweden

and more 12 locations
© Copyright 2025. All Rights Reserved by MedPath